Ophthalmology team recognises the next generation of ophthalmologists as it ran the first Novartis Ophthalmology Case Awards- incorporating the heritage Alcon Glaucoma and Novartis Retina Case Awards
Jun 09, 2017
Fostering the next generation of ophthalmologists is a testament to Novartis commitment to ‘helping people living with eye disease feel better, see better and live better’ – a commitment demonstrated at this year’s finals of the Novartis Ophthalmology Case Awards competition.
Now in its 16th and 8th year respectively, the Glaucoma and Novartis Retina divisions of the case awards aim to foster and share innovation in the understanding of clinical management of ophthalmic disease within the field of ophthalmology. The awards were open to all ophthalmologists in training.
A record number of case reports were submitted this year and a panel of independent experts shortlisted 6 cases in each division to present in person at finals days.
The winners selected by the independent judging panels were in Glaucoma, David Dunleavy and Alastair Porteous and in Retina David Curragh.
For 2017, all our finalists have the opportunity to be published in a peer reviewed journal BMC Ophthalmology as part of the awards.
“For me it has been a great privilege to be involved and to have served on the panel of judges at the Novartis Retina Case awards over the years. Case reports offer great learning opportunities for all of us, from the most junior trainee to the senior specialists as they demonstrate the multitude of ways that a certain disease can present and pose challenges in diagnosis and therapy. For the judges and many delegates who attend this event every year it is a really humbling and inspiring experience to learn from the excellent presentations and the impressive knowledge demonstrated by the finalists,” said Professor Yit Yang, Consultant Ophthalmologist, The Royal Wolverhampton NHS Trust, who has chaired the Retina panel since its inception in 2009.
“The longevity of the award is a testament to our commitment to foster the next generation of ophthalmologists. As a leader in ophthalmology, we want to continue to innovate for patients and recognise the clinical advances made by the ophthalmology community“
Two million people are now living with sight loss in the UK but 50% of these cases are estimated to be preventable. The Novartis Ophthalmology case awards is a great opportunity to recognise and learn from ophthalmologists in the UK
Hear what the finalists and judges have to day about this year’s competition!
Glaucoma Judge - Bruce James: What do you think about using case reports in education?
I think these are very useful! Case studies are a very useful way to learn ophthalmology both in working up the case and actually looking at the literature surrounding any particular case but also reflecting on the case and thinking perhaps what might have been done differently and what alternatives were possible and then sharing that experience with other people I think its an absolutely excellent way to learn and I think it’s an excellent thing to support.
Glaucoma Judge - David Broadway: What do you think about the standard of the presentations?
Extremely high, the use of powerpoint, their ability to present and the management of the case was interesting. The presentations were illustrated well with pictures and videos, using the latest technology. It was really really high standard!
Retina Judge - Yit Yang: What do you think about the standard?
They were really high quality, some of us have done this for several years and each year they are getting more and more impressive. There seems to be no end to how complex eye disease can be and you certainly couldn’t see such high quality submissions.
Glaucoma Finalist – Ibrahim Masri: What do you think about initiatives like this?
I think events like these and initiatives like these are quite useful for learning, but also it encourages us to reflect on our practice which is ultimately to the benefit of the patients. Not just to the person presenting the case but to people listening to our experience because these are unusual cases which we do not see on a day to day basis.
Glaucoma Winner – David Dunleavy: What does winning this award mean to you?
It’s just nice recognition isn’t it of a case we don’t get many days out like this so its just nice to be recognized for it.
What did you think of the standard today?
I thought there were really really good presentations today, very well thought out and well done, well researched! I think its nice to see the interesting cases because you can have your whole career without seeing them in your own unit and it gives you a chance to come hear about them today.
Retina Section Winner - David Curragh: What does this award mean to you?
It means a lot. It’s a case we have been looking after for a number of years and to finalize and complete it with the award and presentation is a nice recognition of a lot of work that has gone into it.
Retina Finalists with Judges
Finalists; Alan Cunningham, Pallavi Tyagi, Farhad Butt, Clare Shute, Shi Zhuan Tan, David Curragh Judges; David Steel, Martin McKibbin, Yit Yang, Erika Damato, Moin Mohammed
Also hear from some of the other finalists who attended the event on their experience and what they thought of the initiative:
You get the opportunity to discuss your case and take something back to your department so it’s a good way of discussing cases and getting feedback even watching your colleagues present you learn something just listening to the peoples cases it’s very good.
It gets the involvement of trainees at every level rather than just at more senior levels. It does introduce you to the research world and you get a lot of input from the senior colleagues as well it’s a great learning opportunity!
I think it also creates a forum that otherwise would not happen. To organize 5 consultants to join together to take time out of their busy time and enable the trainees to come as well it needs the organisation, that’s what Novartis have kindly arranged and put together for us.
Glaucoma Finalists with Judges:
Gurjeet Jutley, SN Chia, Ibrahim Masri, David Broadway(J), Rosemary Robinson(J), Bruce James(J), Colin Goudie, Alastair Porteous, David Dunleavy